反応式
C1C2CCCCC=2C=CC=1N.[CH2:12]([O:14][C:15]([C:17]1[CH:18]=[N:19][N:20]([C:22]2[NH:31][C:30](=[O:32])[C:29]3[C:24](=[CH:25][C:26]4[CH2:36][CH2:35][CH2:34][CH2:33][C:27]=4[CH:28]=3)[N:23]=2)[CH:21]=1)=[O:16])[CH3:13]>>[CH2:12]([O:14][C:15]([C:17]1[CH:18]=[N:19][N:20]([C:22]2[NH:31][C:30](=[O:32])[C:29]3[C:28]4[CH2:36][CH2:35][CH2:34][CH2:33][C:27]=4[CH:26]=[CH:25][C:24]=3[N:23]=2)[CH:21]=1)=[O:16])[CH3:13]参加物
3
実験手順
The titled compound was prepared in a manner analogous to Example 131, steps A-B, using 5,6,7,8-tetrahydro-naphthalen-2-ylamine in step A. Step B yielded a 2:1 mixture of 1-(4-oxo-3,4,6,7,8,9-hexahydro-benzo[g]quinazolin-2-yl)-1H-pyrazole-4-carboxylic acid ethyl ester and the titled compound.
後処理
- customThe titled compound was prepared in a manner analogous to Example 131, steps A-B
- customStep B yielded
出典と根拠
- ORDレコード
- ord-06b0dac4f44646938b8643ded06d85c2
- 出典データセット
- uspto-grants-2015_01
- 特許番号
- US08937078B2
関連ノート
読み込み中…